Reduced epithelial suppressor of cytokine signalling 1 in severe eosinophilic asthma Source: Eur Respir J 2016; 48: 715-725 Year: 2016
PPAR-gamma modulates allergic inflammation through upregulation of PTEN Source: Eur Respir J 2005; 26: Suppl. 49, 25s Year: 2005
A dual role of IL-6 signalling and STAT-3 activation on airway inflammation versus airway hyperresponsiveness in a murine model of asthma Source: Eur Respir J 2002; 20: Suppl. 38, 568s Year: 2002
Increased expression of Lipocalin2 suppresses allergen-induced airway disease in mice Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology Year: 2008
Allergen immunotherapy induces a suppressor memory response that is mediated by IL-10 in a mouse model of asthma Source: Eur Respir J 2003; 22: Suppl. 45, 194s Year: 2003
Upregulated expression of interleukin-33 and alternative activation of macrophages in a model of an acute exacerbation of asthma Source: Annual Congress 2011 - Asthma: basic science and clinical studies Year: 2011
MiR-1165-3p downregulated in Th2 cells inhibits Th2 differentiation in allergic asthma by targeting PPM1A Source: International Congress 2019 – Identification of new targets and therapeutic strategies for lung disease Year: 2019
Differential gene expression and cytokine production from neutrophils in asthma phenotypes Source: Eur Respir J 2010; 35: 522-531 Year: 2010
Overexpression of eNOS suppresses asthmatic features in a mouse model of allergic asthma Source: Eur Respir J 2002; 20: Suppl. 38, 28s Year: 2002
Nlrc5 is involved in allergic airway inflammation and negatively regulates inflammatory signaling pathway via TLR2/NF-?B. Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases Year: 2018
High-level expression of PD-L1 by DC suppresses airway inflammation in OVA-induced allergic asthma Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010
Transgenic mice overexpressing IL-18 display increased IL-13 in the airways but no changes of the airway hyperresponsiveness in a murine model of late-phase asthma: evidence for a dual role of IL-18 on mucosal Th1/Th2 responses Source: Eur Respir J 2002; 20: Suppl. 38, 1s Year: 2002
Resolvin E3 dampens asthmatic inflammation in a murine model through IL-23 pathway Source: International Congress 2019 – Revealing novel asthma immunopathology endotypes Year: 2019
Activated protein C inhibits bronchial inflammation and hyperresponsiveness in a mouse model of asthma Source: Eur Respir J 2002; 20: Suppl. 38, 618s Year: 2002
Disruption of CD44 variant 6 abolished bronchial hyperresponsiveness, inflammation and mast cell myositis in a murine model of asthma Source: Eur Respir J 2006; 28: Suppl. 50, 217s Year: 2006
Overexpression of CBP augments cigarette smoke-induced pro-inflammatory cytokine release in macrophages Source: Eur Respir J 2005; 26: Suppl. 49, 105s Year: 2005
Aerobic training decreases epithelial expression of Th2 cytokines in a murine model of allergic lung inflammation Source: Annual Congress 2007 - Towards an understanding of asthma pathogenesis - novel in vitro assays and results from animal models Year: 2007
The role of suppressor of cytokine signalling 1 (SOCS1) in virus-induced asthma exacerbations Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab Year: 2016
Caspase-1 induces upstream Th2-cytokines IL-33 and TSLP and eosinophilia at viral induced asthma exacerbations Source: International Congress 2016 – Asthma: mechanisms and biomarkers that promote clinical understanding Year: 2016
ILC2 cells from severe allergic and eosinophilic asthma demonstrate increased expression of TSLP receptor (TSLPR) and enhanced proliferative capacity. Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man Year: 2021